Related references
Note: Only part of the references are listed.A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002
Seiji Ito et al.
GASTRIC CANCER (2017)
Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria
Hiroshi Katayama et al.
SURGERY TODAY (2016)
Determination of the optimal cutoff percentage of residual tumors to define the pathological response rate for gastric cancer treated with preoperative therapy (JCOG1004-A)
Kenichi Nakamura et al.
GASTRIC CANCER (2015)
Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para- aortic lymph node dissection for gastric cancer with extensive lymph node metastasis
A. Tsuburaya et al.
BRITISH JOURNAL OF SURGERY (2014)
Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A)
Yukinori Kurokawa et al.
GASTRIC CANCER (2014)
A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma
Inkeun Park et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
A Phase II Study of Systemic Chemotherapy with Docetaxel, Cisplatin, and S-1 (DCS) Followed by Surgery in Gastric Cancer Patients with Extensive Lymph Node Metastasis: Japan Clinical Oncology Group Study JCOG1002
Hiroshi Katayama et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
Japanese classification of gastric carcinoma: 3rd English edition
GASTRIC CANCER (2011)
Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer
T. Yoshikawa et al.
BRITISH JOURNAL OF SURGERY (2009)
Share Paper
